Calliditas Therapeutics
CALT
$38.77
Share price
-2.17%
Change (1 day)
112.55%
Change (1 year)
Categories
Operating Margin for Calliditas Therapeutics (CALT)
Operating Margin as of June 2024 (TTM): -56.67%
According to Calliditas Therapeutics's latest financial reports and stock price the company's current Operating Margin is -56.67%. At the end of 2021 the company had an Operating Margin of -223.84%.
Operating Margin history for Calliditas Therapeutics from 2020 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -223.84% | -99.55% |
| 2020 | -49,902.86% | 283691.14% |
| 2019 | -17.58% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.